Lizhi Niu, PhD
Fuda Cancer Hospital
31
0
24
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (20)
Showing 10 of 20 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Zhenfeng Zhang, MD, PhD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Steven A. Rosenberg, MD, PhD
NCI - Surgery Branch
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
John D. Hainsworth, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Tim F Greten, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (31)
Showing 20 of 31 trials
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
Chimeric Antigen Receptor-Modified T Cells for Breast Cancer
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
CAR-T Cell Immunotherapy for HCC Targeting GPC3
Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli
Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms
Irreversible Electroporation(IRE) For Unresectable Renal Tumors
Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms
Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms
Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms
Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms
Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms
Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms